BRWD1-2-His Reader Domain Assay for compound screening and profiling using the thermoshift assay format to measure compound binding to the target.
Human BRWD1-2 bromodomain, His-tagged
Bromodomain and WD repeat-containing protein 1; WDR9
Thermal stability change after ligand binding
0.1 mg/ml (5.9 µM)
No stabilization was observed in the presence of control compounds (JQ1, PFI1, CBP112, Bromosporine, SGC-CBP30, BET151, RVX-208, GSK2801 and PFI3)
More information can be found on our website Reader Domain Assay Services.